Birmingham Capital Management CO Inc/Al Eli Lilly & CO Transaction History

Birmingham Capital Management CO Inc/Al

$269 Million
Q4 2024

A detailed history of Birmingham Capital Management CO Inc/Al transactions in Eli Lilly & CO stock. As of the latest transaction made, Birmingham Capital Management CO Inc/Al holds 11,400 shares of LLY stock, worth $9.61 Million. This represents 3.28% of its overall portfolio holdings.

Number of Shares

11,400

Previous 12,875 11.46%

Holding current value

$9.61 Million

Previous $11.4 Million 22.85%

% of portfolio

3.28%

Previous 4.17%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Mar 04, 2025	SELL	$727.2 - $932.06 $1.07 Million - $1.37 Million	-1,475 Reduced 11.46%	11,400 $8.8 Million
Q3 2024 Dec 10, 2024	SELL	$772.14 - $960.02 $791,443 - $984,020	-1,025 Reduced 7.37%	12,875 $11.4 Million
Q2 2024 Aug 28, 2024	SELL	$724.87 - $909.04 $1.45 Million - $1.82 Million	-2,005 Reduced 12.61%	13,900 $12.6 Million
Q1 2024 May 29, 2024	SELL	$592.2 - $792.28 $14,805 - $19,807	-25 Reduced 0.16%	15,905 $12.4 Million
Q4 2023 Feb 20, 2024	SELL	$525.19 - $619.13 $309,862 - $365,286	-590 Reduced 3.57%	15,930 $9.29 Million
Q3 2023 Dec 13, 2023	BUY	$434.7 - $599.3 $60,858 - $83,902	140 Added 0.85%	16,520 $8.87 Million
Q2 2023 Sep 19, 2023	SELL	$350.74 - $468.98 $143,803 - $192,281	-410 Reduced 2.44%	16,380 $7.68 Million
Q1 2023 May 22, 2023	BUY	$310.63 - $364.82 $31,063 - $36,482	100 Added 0.6%	16,790 $5.77 Million
Q4 2022 Mar 06, 2023	SELL	$321.55 - $374.67 $27,331 - $31,846	-85 Reduced 0.51%	16,690 $6.11 Million
Q3 2022 Dec 02, 2022	SELL	$296.48 - $337.87 $1.02 Million - $1.16 Million	-3,425 Reduced 16.96%	16,775 $5.42 Million
Q2 2022 Aug 30, 2022	SELL	$278.73 - $327.27 $459,904 - $539,995	-1,650 Reduced 7.55%	20,200 $6.55 Million
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $4,513 - $5,838	-25 Reduced 0.11%	21,850 $5.02 Million
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 0.46%	21,875 $4.09 Million
Q1 2020 Apr 28, 2020	SELL	$119.05 - $147.35 $100,002 - $123,774	-840 Reduced 3.68%	21,975 $3.05 Million
Q4 2019 Feb 03, 2020	SELL	$106.92 - $132.43 $32,076 - $39,729	-300 Reduced 1.3%	22,815 $3 Million
Q3 2019 Nov 05, 2019	SELL	$106.79 - $116.16 $266,975 - $290,400	-2,500 Reduced 9.76%	23,115 $2.59 Million
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $27,827 - $32,755	-250 Reduced 0.97%	25,615 $3.32 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $42,360 - $47,456	-400 Reduced 1.52%	25,865 $2.99 Million
Q1 2018 Apr 24, 2018	SELL	$74.21 - $87.6 $166,972 - $197,100	-2,250 Reduced 7.89%	26,265 $2.03 Million
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $2.34 Million - $2.51 Million	28,515	28,515 $2.41 Million

Others Institutions Holding LLY

# of Institutions

4,289

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $801B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birmingham Capital Management CO Inc/Al, based on Form 13F filings with the SEC.

News

Stay updated on Birmingham Capital Management CO Inc/Al with notifications on news.

Account

Birmingham Capital Management CO Inc/Al Eli Lilly & CO Transaction History